
Sermorelin is a GHRH(1-29) fragment and historically the first growth hormone releasing hormone analog studied clinically, with a short half-life on its own. It belongs to the GHRH-receptor family studied for stimulating the pituitary's own GH release. Increases in GH and IGF-1 are established pharmacology; long-term functional outcomes have not been established.
$50.00
In stock
For laboratory research use only. Not for human consumption.